Literature DB >> 17626305

The Th1/Th2 paradigm: still important in pregnancy?

Gérard Chaouat1.   

Abstract

The enunciation of the T helper 1/T helper 2 (Th1/Th2) paradigm in pregnancy has represented a major step forward in our understanding of physiological and pathologic materno-foetal relationship. However, recent developments in studies of the implantation process and in the emergence of the uterine vascular bed and its control by natural killer cells and cytokines suggest that one must go beyond this hitherto useful scheme. In this review, we replace the emergence of the paradigm in its historical context and then emphasises what it does explain and what it no longer account for. A final reappraisal of the paradigm is suggested.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626305     DOI: 10.1007/s00281-007-0069-0

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   11.759


  160 in total

Review 1.  The interleukin-1 system and human implantation.

Authors:  C Simón; A Mercader; M J Gimeno; A Pellicer
Journal:  Am J Reprod Immunol       Date:  1997-01       Impact factor: 3.886

2.  Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft".

Authors:  S P Jiang; M S Vacchio
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

Review 3.  Is there a Th2 bias in human pregnancy?

Authors:  G S Vince; P M Johnson
Journal:  J Reprod Immunol       Date:  1996-12       Impact factor: 4.054

4.  Facilitation reaction (enhancing antibodies and suppressor cells) and rejection reaction (sensitized cells) from the mother to the paternal antigens of the conceptus.

Authors:  G Chaouat; G A Voisin; D Escalier; P Robert
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

5.  Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology.

Authors:  E I Ntrivalas; J Y Kwak-Kim; A Gilman-Sachs; H Chung-Bang; S C Ng; K D Beaman; H P Mantouvalos; A E Beer
Journal:  Hum Reprod       Date:  2001-05       Impact factor: 6.918

6.  Maternal anti-placental reactivity in natural, immunologically-mediated fetal resorptions.

Authors:  S Tangri; T G Wegmann; H Lin; R Raghupathy
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

7.  Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy.

Authors:  Ali A Ashkar; Gordon P Black; Qingxia Wei; Hong He; Luchuan Liang; Judith R Head; B Anne Croy
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

8.  The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a Listeria monocytogenes infection.

Authors:  Ellen M Barber; Jeffrey W Pollard
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

9.  Interleukin 2 receptor gamma chain (gamma(c)) knockout mice show less regularity in estrous cycle but achieve normal pregnancy without fetal compromise.

Authors:  Satomi Miyazaki; Kyoko Tanebe; Masatoshi Sakai; Toshihiko Michimata; Hiroshi Tsuda; Masaki Fujimura; Masataka Nakamura; Yasuo Kiso; Shigeru Saito
Journal:  Am J Reprod Immunol       Date:  2002-04       Impact factor: 3.886

10.  Regulatory T cells mediate maternal tolerance to the fetus.

Authors:  Varuna R Aluvihare; Marinos Kallikourdis; Alexander G Betz
Journal:  Nat Immunol       Date:  2004-02-01       Impact factor: 25.606

View more
  59 in total

Review 1.  Pregnancy and rheumatoid arthritis: insights into the immunology of fetal tolerance and control of autoimmunity.

Authors:  Shreyasee Amin; Erik J Peterson; Ann M Reed; Daniel L Mueller
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

Review 2.  Fetomaternal immune cross-talk and its consequences for maternal and offspring's health.

Authors:  Petra C Arck; Kurt Hecher
Journal:  Nat Med       Date:  2013-05-07       Impact factor: 53.440

Review 3.  Prenatal Stress, Maternal Immune Dysregulation, and Their Association With Autism Spectrum Disorders.

Authors:  David Q Beversdorf; Hanna E Stevens; Karen L Jones
Journal:  Curr Psychiatry Rep       Date:  2018-08-09       Impact factor: 5.285

4.  Embryonic intraventricular exposure to autism-specific maternal autoantibodies produces alterations in autistic-like stereotypical behaviors in offspring mice.

Authors:  Jasmin Camacho; Karen Jones; Elaine Miller; Jeanelle Ariza; Stephen Noctor; Judy Van de Water; Verónica Martínez-Cerdeño
Journal:  Behav Brain Res       Date:  2014-03-05       Impact factor: 3.332

Review 5.  The use of biologics for autoimmune rheumatic diseases in fertility and pregnancy.

Authors:  May Ching Soh; Marcelo Moretto
Journal:  Obstet Med       Date:  2019-05-30

6.  Ozone Exposure During Implantation Increases Serum Bioactivity in HTR-8/SVneo Trophoblasts.

Authors:  Colette N Miller; Erica J Stewart; Samantha J Snow; Wanda C Williams; Judy H Richards; Leslie C Thompson; Mette C Schladweiler; Aimen K Farraj; Urmila P Kodavanti; Janice A Dye
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

Review 7.  The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome.

Authors:  Rohan Willis; E B Gonzalez; A R Brasier
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

Review 8.  The protective role of antibody responses during Mycobacterium tuberculosis infection.

Authors:  F Abebe; G Bjune
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

9.  Placental oxidative stress alters expression of murine osteogenic genes and impairs fetal skeletal formation.

Authors:  M R Prater; C L Laudermilch; C Liang; S D Holladay
Journal:  Placenta       Date:  2008-09       Impact factor: 3.481

Review 10.  Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?

Authors:  Leigh R Guerin; Jelmer R Prins; Sarah A Robertson
Journal:  Hum Reprod Update       Date:  2009-03-11       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.